Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Investor Relations
Overview
Stock Quote
Presentations
Frequently Asked Questions
Press Kit
SEC Filings
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Overview

Welcome to the Nutra Pharma Investor Relations homepage.
In this section, you can access our stock quotes, corporate presentations, frequently asked questions and SEC filings.

Stock Symbol: NPHC
Exchange: OTC
Last Trade: 0.0076*
Change: -0.0008
*Quote delayed 20 minutes.
The SEC requires public companies to post their XBRL files on their corporate websites for at least 12 months. The following provides links to Nutra Pharma's XBRL data
XBRL files for Form 10Q For the quarter ended 9/30/2015.

Please click here to download the zipped files.

XBRL files for Form 10K For the year ended 12/31/2015.

Please click here to download the zipped files.

XBRL files for Form 10Q For the quarter ended 3/31/2016.

Please click here to download the zipped files.

XBRL files for Form 10Q For the quarter ended 6/30/2016.

Please click here to download the zipped files.

XBRL files for Form 10Q For the quarter ended 9/30/2016.

Please click here to download the zipped files.

For all Public Filings for Nutra Pharma:

Please click here

 

Analyst Report

Nutra Pharma was recently featured in a Comprehensive report issued by See Thru Equities - an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report can be viewed on the following link:Download here

 
 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
February 15, 2017
Nutra Pharma and Nyloxin Featured on NBC News-Miami


December 27, 2016
Nutra Pharma Letter to Shareholders


November 15, 2016
Nutra Pharma Announces Infomercial Campaign for Pet Pain-Away


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics